Caricamento...
Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
INTRODUCTION: Methimazole (MMI) is the treatment of choice for patients with Graves’ disease. The major drawback of this treatment is the relapse of hyperthyroidism in half of the patients after discontinuation of the recommended conventional 12–18 months of MMI treatment. TSH receptor antibody (TRA...
Salvato in:
| Pubblicato in: | J Med Case Rep |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8063397/ https://ncbi.nlm.nih.gov/pubmed/33888159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02788-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|